Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy FSD Pharma stock
Learn how to easily invest in FSD Pharma stock.
FSD Pharma Inc is a drug manufacturers-specialty & generic business based in the US. FSD Pharma shares (HUGE) are listed on the NASDAQ and all prices are listed in US Dollars. FSD Pharma employs 9 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in FSD Pharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HUGE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
FSD Pharma stock price (NASDAQ: HUGE)Use our graph to track the performance of HUGE stocks over time.
FSD Pharma shares at a glance
|Latest market close||$0.87|
|52-week range||$0.83 - $4.44|
|50-day moving average||$1.18|
|200-day moving average||$1.54|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.13|
Buy FSD Pharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy FSD Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
FSD Pharma price performance over time
|1 week (2022-01-20)||-14.23%|
|1 month (2021-12-24)||N/A|
|3 months (2021-10-28)||-37.06%|
|6 months (2021-07-28)||-48.84%|
|1 year (2021-01-28)||-57.94%|
|2 years (2020-01-28)||-86.27%|
|3 years (2019-01-28)||272.30%|
|5 years (2017-01-24)||N/A|
Is FSD Pharma stock undervalued or overvalued?
Valuing FSD Pharma stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of FSD Pharma's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
FSD Pharma's EBITDA
FSD Pharma's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $428,232.
The EBITDA is a measure of a FSD Pharma's overall financial performance and is widely used to measure a its profitability.
FSD Pharma financials
|Gross profit TTM||$-3,331,945|
|Return on assets TTM||-37.87%|
|Return on equity TTM||-68.93%|
|Market capitalisation||$37.4 million|
TTM: trailing 12 months
FSD Pharma share dividends
We're not expecting FSD Pharma to pay a dividend over the next 12 months.
Have FSD Pharma's shares ever split?
FSD Pharma's shares were split on a 1:201 basis on 15 October 2019. So if you had owned 201 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your FSD Pharma shares – just the quantity. However, indirectly, the new 20000% higher share price could have impacted the market appetite for FSD Pharma shares which in turn could have impacted FSD Pharma's share price.
FSD Pharma share price volatility
Over the last 12 months, FSD Pharma's shares have ranged in value from as little as $0.8251 up to $4.44. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while FSD Pharma's is 1.0303. This would suggest that FSD Pharma's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
FSD Pharma overview
FSD Pharma Inc. , through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA. ; and with Innovet Italia S. R.
FSD Pharma in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Frequently asked questionsWhat percentage of FSD Pharma is owned by insiders or institutions?
Currently 13.114% of FSD Pharma shares are held by insiders and 5.639% by institutions. How many people work for FSD Pharma?
Latest data suggests 9 work at FSD Pharma. When does the fiscal year end for FSD Pharma?
FSD Pharma's fiscal year ends in December. Where is FSD Pharma based?
FSD Pharma's address is: 199 Bay Street, Toronto, ON, Canada, M5L 1A9 What is FSD Pharma's ISIN number?
FSD Pharma's international securities identification number is: CA35954B2066 What is FSD Pharma's CUSIP number?
FSD Pharma's Committee on Uniform Securities Identification Procedures number is: 35954B206
More guides on Finder
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Stocks are dropping; 3 rules for buying on the dip
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
How to buy Specialty Building Products (SBP) stock when it goes public
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
Ask an Expert